ERSTE STOCK BIOTEC HUF R01 (VTA)/ AT0000A18XC5 /
| NAV14/06/2024 | Chg.+2055.4844 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 208,398.3125HUF | +1.00% | Full reinvestment | Equity Sector Biotechnology | Erste AM ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014 | - | - | - | - | - | - | - | 10.56 | 2.95 | 6.31 | 2.92 | 6.57 | - |
| 2015 | 11.45 | 4.28 | 5.13 | -4.18 | 10.61 | -1.30 | 5.50 | -7.32 | -17.86 | 14.82 | 7.76 | -2.91 | +23.32% |
| 2016 | -26.53 | -1.59 | -4.77 | 8.88 | 3.63 | -6.64 | 11.02 | -2.64 | 3.01 | -6.30 | 12.59 | -5.41 | -19.41% |
| 2017 | 0.71 | 9.05 | -1.97 | 1.35 | -8.66 | 8.04 | -0.28 | 0.15 | 5.20 | -3.80 | -2.84 | 3.87 | +9.84% |
| 2018 | 2.33 | -1.99 | -4.32 | 1.44 | 10.03 | 4.85 | 0.96 | 9.99 | -2.12 | -14.11 | 2.87 | -13.10 | -6.29% |
| 2019 | 16.36 | 9.53 | -3.63 | 0.27 | -3.63 | 4.17 | 3.02 | -4.51 | -4.26 | 4.23 | 14.57 | -0.84 | +37.88% |
| 2020 | -2.06 | -2.89 | -0.46 | 13.15 | 2.21 | 1.81 | -7.36 | -2.88 | 4.72 | 1.06 | -1.08 | 2.92 | +8.06% |
| 2021 | 2.22 | -2.50 | -2.36 | -1.51 | -7.69 | 9.35 | -0.24 | 1.14 | 0.51 | -1.16 | -0.22 | 1.44 | -1.86% |
| 2022 | -13.77 | 0.16 | 5.61 | 1.83 | -0.92 | 3.52 | 9.41 | 0.85 | 5.92 | 3.73 | -3.09 | -5.25 | +6.03% |
| 2023 | -2.30 | -5.24 | -1.51 | -0.34 | -0.52 | -1.02 | 3.81 | -0.55 | 2.64 | -9.61 | -0.93 | 14.40 | -2.85% |
| 2024 | 2.48 | 5.72 | -2.44 | -6.44 | -0.37 | 7.51 | - | - | - | - | - | - | - |
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 16.96% | 18.21% | 18.24% | 24.12% | 26.29% |
| Ratio de Sharpe | 0.59 | 0.58 | 0.33 | 0.02 | 0.08 |
| Le meilleur mois | +14.40% | +14.40% | +14.40% | +14.40% | +14.57% |
| Le plus défavorable mois | -6.44% | -6.44% | -9.61% | -13.77% | -13.77% |
| Perte maximale | -10.87% | -10.87% | -12.13% | -24.25% | -29.00% |
| Surperformance | -1.51% | - | -7.87% | -33.09% | -35.72% |
Toutes les cotations dans HUF
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 2,965.9099 | +6.35% | -3.39% | |
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 49,767.3516 | +10.77% | +15.89% | |
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 122.8100 | +3.13% | -0.16% | |
| ERSTE Stock Biotec D01 A | paying dividend | 119.7600 | +2.48% | -0.80% | |
| ERSTE Stock Biotec D01 T | reinvestment | 118.8200 | +2.48% | -0.79% | |
| ERSTE STOCK BIOTEC HUF R01 (VTA) | Full reinvestment | 208,398.3125 | +9.65% | +12.91% | |
| ERSTE STOCK BIOTEC CZK R01 (VTA) | Full reinvestment | 12,978.9902 | +6.29% | -3.46% | |
| ERSTE STOCK BIOTEC EUR R01 (VTA) | Full reinvestment | 525.9800 | +2.47% | -0.82% | |
| ERSTE STOCK BIOTEC EUR R01 (A) | paying dividend | 479.1500 | +2.49% | -0.81% | |
| ERSTE STOCK BIOTEC EUR R01 (T) | reinvestment | 479.1200 | +2.49% | -0.81% |
Performance
| CAD | +5.92% | ||
|---|---|---|---|
| 6 Mois | +6.92% | ||
| 1 An | +9.65% | ||
| 3 Ans | +12.91% | ||
| 5 Ans | +32.94% | ||
| 10 ans | - | ||
| Depuis le début | +129.81% | ||
| Année | |||
| 2023 | -2.85% | ||
| 2022 | +6.03% | ||
| 2021 | -1.86% | ||
| 2020 | +8.06% | ||
| 2019 | +37.88% | ||
| 2018 | -6.29% | ||
| 2017 | +9.84% | ||
| 2016 | -19.41% | ||
| 2015 | +23.32% | ||
